Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Shanghai Everest Medicines in-licensed a BTK inhibitor...
Chia Tai‑Tianqing Pharma (CTTQ), a Nanjing subsidiary...
Shanghai Junshi Bio has formed a JV with...
Hangzhou Lynk Pharmaceuticals closed a $16 million Series...
Shenzhen Kexing Biopharm has started a Phase III clinical...
Perhaps this is the adolescent phase of China biopharma...
Gains 24% and leads biotechs today. More details...
It will be hot in New Orleans this June, and we don't...
The gene expression wars heat up as Applied Bio launches...
The biotech nuclear winter is clearly over - but could...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
